证券代码：688203 证券简称：海正生材 公告编号：2025-41 浙江海正生物材料股份有限公司 2025年第二次临时股东会决议公告 （二） 股东会召开的地点：浙江省台州市台州湾新区台州湾大道 188 号浙江海 诺尔生物材料有限公司会议室 （三） 出席会议的普通股股东及其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 71 | | --- | --- | | 普通股股东人数 | 71 | | 2、出席会议的股东所持有的表决权数量 | 120,858,933 | | 普通股股东所持有表决权数量 | 120,858,933 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 60.0703 | | 例（%） | | | | | 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 7 月 31 日 注：截至本次股东会股权登记日，公司总股本为 202,678,068 股，其中公司回购专用账户 ...

Core Viewpoint - Haizheng Biomaterials (688203.SH) has faced significant challenges after its initial public offering, with declining profits and increasing competition in the polylactic acid (PLA) market despite being a pioneer in the industry [3][4][7]. Financial Performance - The company reported its best profit in 2022, but subsequent years have seen a decline in net profit, with decreases of 7.41% in 2023, 18.47% in 2024, and a staggering 97.45% in Q1 2025 [4][6]. - Revenue for 2024 was 845 million, a year-on-year increase of 12.2%, but the gross margin fell to 12.71% in 2024, down 0.33 percentage points from 2023 [20][23]. Market Position and Competition - Haizheng Biomaterials is the first domestic and second global company to commercialize PLA production, holding a leading market share in China [7][47]. - The industry has seen rapid capacity expansion following domestic technological breakthroughs, leading to potential oversupply and reduced profitability [7][40][46]. Production Capacity and Delays - The company has faced delays in expanding its production capacity, with the initial plan for a 150,000-ton annual capacity project being adjusted to a phased implementation due to market conditions [24][26][27]. - As of the end of 2024, the first phase of the project was 70% complete, while the second phase was only 15% complete, with further delays anticipated [27]. Industry Dynamics - The PLA industry benefits from government support for biodegradable materials, with PLA projected to account for 37.1% of the bio-based materials market by 2024 [28][30]. - However, demand is primarily driven by policy rather than market forces, leading to challenges in adoption due to higher costs compared to traditional plastics [38][49]. Product Development - The company has developed various PLA grades tailored for different applications, including 3D printing, which saw a 185.67% increase in sales in 2024 [34][35]. - The revenue from modified PLA resins reached 187 million in 2024, indicating a focus on diversifying product offerings [35]. Future Outlook - Despite the promising market for biodegradable materials, the rapid expansion of production capacity across the industry poses a risk of oversupply, reminiscent of the solar energy sector's challenges [49].

Investment Rating - The report rates the industry as "Outperform" [1] Core Insights - BYD has achieved a global milestone by realizing L4-level intelligent parking, allowing drivers to be hands-free under specific conditions, with liability on automobile companies [5][12] - xAI has released Grok-4, a next-generation large model that has seen a tenfold increase in reasoning capabilities compared to its predecessor, excelling in various benchmarks and outperforming human graduate-level academic abilities [5][13] - The Ministry of Industry and Information Technology has issued the 2025 Work Points for Integration of Informatization and Industrialization, emphasizing new industrialization and supporting software development, AI empowerment, and digital transformation [5][14] Summary of Related Companies - Recommended targets include: Empyrean Technology, Dameng Data, Beijing Kingsoft Office Software, Newland Digital Technology, Jiangsu Tongxingbao Intelligent Transportation Technology Co., Ltd., Kingdee International Software Group, Hehe Information; related target: Wuxi Unicomp Technology Co., Ltd. [5][11] - BYD's advantages in assisted driving and manufacturing ensure safety for users in the Chinese market, boosting trust in intelligent parking [5][12] - Grok-4 has demonstrated strong capabilities in real-world applications, including significant improvements in voice response speed and performance in complex tasks across various industries [5][13]

Group 1 - The company will hold its second extraordinary general meeting of shareholders in 2025 to discuss various proposals, including the cancellation of the supervisory board and amendments to the company's articles of association [2][8][10] - The meeting will ensure the orderly conduct of proceedings and protect the rights of shareholders, with specific rules for attendance and participation [3][4][5] - The company has proposed to replace the supervisory board's functions with the audit committee of the board of directors, which will require amendments to relevant governance documents [8][10] Group 2 - The company has nominated Wang Fang as a candidate for a non-independent director position on the board, following the resignation of Wang Haiyan due to work commitments [12][13] - Wang Fang has a background in finance and has held various positions in financial institutions and state-owned enterprises, which aligns with the company's governance needs [12][13] - The election of Wang Fang will also lead to her appointment to the remuneration and assessment committee of the board, ensuring compliance with governance structure [13][14]

海正生材 2025 年第二次临时股东会会议资料 证券代码：688203 证券简称：海正生材 浙江海正生物材料股份有限公司 2025 年第二次临时股东会会议资料 二○二五年七月三十一日 海正生材 2025 年第二次临时股东会会议资料 浙江海正生物材料股份有限公司 2025 年第二次临时股东会资料目录 | 2025 | 年第二次临时股东会会议须知 2 | | --- | --- | | 2025 | 年第二次临时股东会会议议程 4 | | | 议案一：关于取消监事会并修订《公司章程》及其附件的议案 6 | | | 议案二：关于修订部分公司治理制度的议案 7 | | 2.01 | 关于修订《浙江海正生物材料股份有限公司防止大股东及关联方占用公司资 | | | 金管理制度》的议案 | | 2.02 | 关于修订《浙江海正生物材料股份有限公司累积投票制实施细则》的议案 | | 2.03 | 关于修订《浙江海正生物材料股份有限公司独立董事工作制度》的议案 | | 2.04 | 关于修订《浙江海正生物材料股份有限公司董事会审计委员会工作细则》的 | | 议案 | | | 2.05 | 关于修订《浙江海正生物材料股份有限公司 ...

Investment Rating - The report indicates a positive investment outlook for the consumer-grade 3D printing industry, highlighting significant growth potential driven by various demand factors and technological advancements [3][79]. Core Insights - The consumer-grade 3D printing market is expected to reach USD 7.1 billion by 2028, with a compound annual growth rate (CAGR) of 19.2% from 2022 to 2028 [3][83]. - Key demand drivers include the rise of the maker movement in Europe and the U.S., the DIY culture, and the increasing consumer interest in personalized products [3][39]. - The supply side is characterized by technological advancements, a diverse material spectrum, and the establishment of community ecosystems that enhance customer engagement [3][91]. Summary by Sections 1. Market Overview - The consumer-grade 3D printing market is primarily designed for individual users and small businesses, offering ease of use and lower costs compared to industrial-grade printers [3][10]. - The market is witnessing rapid growth, with significant contributions from the U.S. and European markets, driven by high consumer spending power and interest in technology [3][47]. 2. Demand Drivers - The report identifies four main demand drivers: 1. The "garage innovation" culture in the U.S. and Europe, which promotes the adoption of desktop devices [3][39]. 2. The DIY trend among consumers, allowing for personalized product creation [3][40]. 3. The tool-like attributes of 3D printers for small businesses and educational institutions [3][59]. 4. The influence of trendy collectible products that enhance consumer interest [3][70]. 3. Supply Trends - The supply side is evolving with advancements in technology, including multi-functional devices and AI integration, which lower operational barriers for users [3][91]. - The materials used in 3D printing are becoming more diverse, allowing for a wider range of applications [3][106]. - Community ecosystems are being built to retain customer loyalty and encourage new entrants through crowdfunding opportunities [3][110]. 4. Key Players - Core companies identified in the report include: 1. Key components: Jieput, Ruike Laser, and Jinchengzi [3]. 2. 3D scanning accessories: Sikan Technology and Orbbec [3]. 3. Materials: Haizheng Materials, Huitong Technology, and Jialian Technology [3]. 4. Complete machines: Anker Innovation and others [3][28]. 5. Market Statistics - In 2024, China's 3D printer exports are projected to reach USD 1.147 billion, with a year-on-year growth of 31.09% [3][80]. - The report notes that over 90% of entry-level 3D printers globally are supplied by Chinese manufacturers, indicating a strong competitive position in the market [3][88].

General Principles - The management system for the resignation of directors and senior management at Zhejiang Haizheng Biological Materials Co., Ltd. aims to standardize the resignation process and ensure corporate governance stability and shareholder rights [1][2] - This system applies to all directors (including independent directors) and senior management personnel of the company [1] Resignation Circumstances and Effectiveness - Directors can resign before their term ends by submitting a written resignation report, which becomes effective upon receipt by the board [3][4] - The company must complete the election of new directors within 60 days of a resignation to ensure compliance with legal and charter requirements [2][4] - Non-employee representative directors are elected by the shareholders' meeting, while employee representative directors are elected by the employee representative assembly [2] Responsibilities and Obligations of Resigning Directors and Senior Management - Resigning directors and senior management must ensure a proper handover of work and may be subject to exit audits [5][6] - The company will track and supervise the fulfillment of any public commitments made by resigning directors and senior management during their tenure [5][6] - The fiduciary duties of directors and senior management continue for six months after resignation, and they remain liable for any breaches during their tenure [6][7] Additional Provisions - The system stipulates that directors and senior management must comply with relevant laws and regulations, and any violations resulting in losses to the company will incur liability [6][7] - The system will take effect upon approval by the company's board and will be interpreted by the board [7]

Core Viewpoint - Zhejiang Haizheng Biological Materials Co., Ltd. has decided to abolish its supervisory board and transfer its responsibilities to the audit committee of the board of directors, aiming to enhance internal governance and operational efficiency [1][2][3]. Group 1: Board Meeting Decisions - The seventh board of directors held its sixteenth meeting on July 15, 2025, with all 8 directors present, confirming the legality and validity of the meeting [1]. - The board approved the proposal to cancel the supervisory board and amend the company's articles of association and related governance documents [1][2]. - The board also approved the revision and establishment of several corporate governance systems to align with the cancellation of the supervisory board [2][3]. Group 2: Voting Results - All proposals discussed during the meeting received unanimous support, with 8 votes in favor and no votes against or abstentions [2][3][4]. Group 3: Director Changes - The board accepted the resignation of director Wang Haiyan and nominated Wang Fang as a candidate for the board, pending approval at the upcoming shareholders' meeting [3][4]. - Wang Fang will also be elected as a member of the remuneration and assessment committee upon her approval as a director [4]. Group 4: Upcoming Shareholders' Meeting - The board has scheduled the second extraordinary shareholders' meeting for July 31, 2025, to review the matters discussed in the board meeting [4].

Meeting Information - The second extraordinary general meeting of shareholders for 2025 will be held on July 31, 2025, at 14:00 at the conference room of Zhejiang Hainuoer Biomaterials Co., Ltd. [1][2] - The meeting will adopt a combination of on-site voting and online voting through the Shanghai Stock Exchange's network voting system [2][4]. Voting Procedures - Shareholders can vote through the Shanghai Stock Exchange's network voting system from 9:15 to 15:00 on the day of the meeting [1][4]. - Specific voting procedures for margin trading, transfer, and other related accounts must comply with relevant regulations [2]. Agenda Items - The meeting will review several non-cumulative voting proposals, including amendments to the company's funding management system and the election of a non-independent director [2][3][10]. - All proposals have been approved by the company's seventh board of directors at its sixteenth meeting [2]. Attendance and Registration - Shareholders must register to attend the meeting, either in person or by authorizing a proxy [5][8]. - Registration must be completed by July 29, 2025, for non-on-site attendees [5][10]. Communication and Reminders - The company will utilize a reminder service to notify shareholders about the meeting and voting procedures [9][10]. - Contact information for inquiries includes a phone number and email address for shareholder assistance [10].

证券代码：688203 证券简称：海正生材 公告编号：2025-39 浙江海正生物材料股份有限公司 根据《公司法》《公司章程》及相关规定，王海燕女士辞职后不会导致公司 董事会成员低于法定最低人数，不会影响董事会依法规范运作，也不会影响公司 正常的经营发展，王海燕女士的辞职报告自送达公司董事会之日起生效。 截至本公告披露之日，王海燕女士未持有公司股份，不存在应当履行而未履 行的承诺事项。公司董事会对王海燕女士在任职期间为公司发展作出的贡献表示 衷心感谢！ 二、补选董事候选人的情况 关于公司董事辞职暨补选董事候选人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江海正生物材料股份有限公司（以下简称"公司"）董事会近日收到王海 燕女士提交的书面辞职报告。因工作需要，王海燕女士辞去公司董事、董事会薪 酬与考核委员会委员职务，王海燕女士辞职后将不再担任公司任何职务。根据控 股股东浙江海正集团有限公司推荐，董事会提名委员会审核通过了董事候选人任 职资格，董事会同意提名王芳女士为公司第七届董事会董事候选人，该议案尚 ...